腸聖內服液 Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

腸聖內服液

通台元記貿易股份有限公司 台北巿復興北路156號7樓 (11633404) - proteus vulgaris;;colibacillus;;enterococcus;;strphylococcus - 內服液劑 - colibacillus (5608001500) 100billi; enterococcus (5608001600) 60billi; strphylococcus (5608001700) 20billi; proteus vulgaris (5608001800) 10billi - 急、慢性腸過敏症、腸中毒之併發症

益綜鎮 Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

益綜鎮

通台元記貿易股份有限公司 台北巿復興北路156號7樓 (11633404) - hexamidine - 眼耳鼻用液劑 - hexamidine (8404000400) 0.1% - 結膜炎、沙眼、角膜炎、中耳炎、鼻竇炎

普生安肝/MA Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

普生安肝/MA

普生股份有限公司 新竹巿科學工業園區創新一路6號 (47299918) - hepatitis a, antigen;;o-phenylenediamine 2hcl (opd);;phosphate plug (phosphate buffer);;hydrogen peroxide;;serum, antibody, human igm;;serum, human normal;;hepatitis a, antibody, igm;;hepatitis a, antibody, peroxidase - 試劑 - hydrogen peroxide (5204900500) (citr. phosphate; hepatitis a, antigen (8081110000) ; hepatitis a, antibody, peroxidase (8081120200) ; hepatitis a, antibody, igm (8081120300) ; serum, human normal (8082000100) ; serum, antibody, human igm (8082000400) (rabbit bead); o-phenylenediamine 2hcl (opd) (8084000100) ; phosphate plug (phosphate buffer) (9600036600) - 酵素免疫法測定A型肝炎IGM抗體(ANTI-HAV IGM)

B型肝炎核心抗體酵素免疫法試劑 Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

B型肝炎核心抗體酵素免疫法試劑

台灣亞培大藥廠股份有限公司 台北巿民生東路三段49號六樓 (23928728) - serum, human normal;;serum, antibody, human igm;;hepatitis b, antibody, core;;hydrogen peroxide;;phosphate plug (phosphate buffer);;serum, anti-hbc;;hepatitis b, antigen, core;;o-phenylenediamine 2hcl (opd) - 試劑 - hydrogen peroxide (5204900500) 0.02%; hepatitis b, antigen, core (8081212000) ; hepatitis b, antibody, core (8081222000) ; serum, human normal (8082000100) ; serum, antibody, human igm (8082000400) (beads); serum, anti-hbc (8082001200) ; o-phenylenediamine 2hcl (opd) (8084000100) ; phosphate plug (phosphate buffer) (9600036600) - 檢驗血清中B型肝炎核心抗原之IGM抗體

普生益肝/B Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

普生益肝/B

普生股份有限公司 新竹縣寶山鄉新竹園區創新一路6號 (47299918) - o-phenylenediamine 2hcl (opd);;serum, hbeag;;hepatitis b, antibody, e, peroxidase;;serum, human normal;;hepatitis b, antibody, e;;hydrogen peroxide - 診斷用試劑 - hydrogen peroxide (5204900500) citr. phos./0.02%; hepatitis b, antibody, e (8081223000) (beads); hepatitis b, antibody, e, peroxidase (8081223200) ; serum, human normal (8082000100) ; serum, hbeag (8082000800) ; o-phenylenediamine 2hcl (opd) (8084000100) - 酵素免疫法測定B型肝炎E抗原HBEAG

普生益肝碘125BN Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

普生益肝碘125BN

普生股份有限公司 新竹縣寶山鄉新竹園區創新一路6號 (47299918) - hepatitis b, antibody, e, i-125;;serum, anti-hbe;;hepatitis b, antibody, e;;serum, hbeag;;serum, human normal - 診斷用試劑 - hepatitis b, antibody, e (8081223000) (beads); hepatitis b, antibody, e, i-125 (8081223100) ; serum, human normal (8082000100) ; serum, hbeag (8082000800) ; serum, anti-hbe (8082001300) - 放射免疫法測定B型肝炎E抗原(HBEAG)或B型肝炎E抗體(ANTI-HBE)

爾必得舒 注射液 5 毫克/毫升 Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

爾必得舒 注射液 5 毫克/毫升

台灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610) - cetuximab, chimeric antibody - 注射劑 - cetuximab, chimeric antibody (1013000900) mg - cetuximab - 適用於治療ras原生型(wild-type)之轉移性直腸結腸癌病人• 與folfiri (folinic acid/ 5-fu/ irinotecan)合併使用之第一線治療。• 與folfox合併使用之第一線治療。併用encorafenib,⽤於治療帶有braf v600e 突變且曾接受過治療之轉移性直腸結腸癌 (crc) 成人病人。與放射線療法合併使用,治療局部晚期之口咽癌、下咽癌及喉癌病人。與內含platinum類之化學療法合併使用,治療復發及/或轉移性頭頸部鱗狀細胞癌病人。

爾必得舒注射液 Taiwan - Chinees - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

爾必得舒注射液

臺灣默克股份有限公司 台北市內湖區堤頂大道2段89號6樓 (23526610) - cetuximab, chimeric antibody - 注射劑 - cetuximab, chimeric antibody (1013000900) mg - cetuximab - erbitux與folfiri(folinic acid/5-fu/irinotecan)合併使用於治療具表皮生長因子受體表現型(egfr expressing),kras原生型(wild-type)之轉移性直腸結腸癌病患之第一線治療。erbitux與放射線療法合併使用,治療局部晚期之口咽癌、下咽癌及喉癌患者。erbitux與內含platinum類之化學療法合併使用,治療復發及/或轉移性頭頸部鱗狀細胞癌患者。